178 related articles for article (PubMed ID: 38395921)
41. Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma.
Ferrara F; Ravasio R
Clin Drug Investig; 2008; 28(1):55-65. PubMed ID: 18081361
[TBL] [Abstract][Full Text] [Related]
42. Complete resolution of autoimmune thyroiditis after R-CHOP in a patient with thyroid lymphoma.
Sleddering MA; Vlasveld LT
Neth J Med; 2015 Dec; 73(10):478-80. PubMed ID: 26687264
[TBL] [Abstract][Full Text] [Related]
43. Non-Hodgkin's lymphoma presenting as thyroid and adrenal gland involvement.
Erdoğan G; Güllü S; Colak T; Kamel AN; Başkal N; Ekinci C
Endocr J; 1997 Feb; 44(1):199-203. PubMed ID: 9152635
[TBL] [Abstract][Full Text] [Related]
44. Primary diffuse large B-cell lymphoma in the maxilla: A case report.
Zou H; Yang H; Zou Y; Lei L; Song L
Medicine (Baltimore); 2018 May; 97(20):e10707. PubMed ID: 29768336
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic fine-needle aspiration cytology and immunocytochemistry analysis of a primary thyroid lymphoma presenting as an anatomic emergency.
Van den Bruel A; Drijkoningen M; Oyen R; Vanfleteren E; Bouillon R
Thyroid; 2002 Feb; 12(2):169-73. PubMed ID: 11916287
[TBL] [Abstract][Full Text] [Related]
46. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
[TBL] [Abstract][Full Text] [Related]
47. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
48. Primary diffuse large B-cell lymphoma of the Larynx.
Higo R; Kojima M; Itoh S; Noguchi M; Izumi H; Takeuchi K
Auris Nasus Larynx; 2023 Aug; 50(4):632-636. PubMed ID: 35863932
[TBL] [Abstract][Full Text] [Related]
49. Rare case of primary bone lymphoma of the femur.
Kiamos A; Boldig K; Gagadam V; Gujarathi R
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474139
[TBL] [Abstract][Full Text] [Related]
50. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D; Nagpal S; Lechowicz MJ; Gaur R; Lucas A; Melani C; Roschewski M; Steinberg SM; Jaffe ES; Kahl B; Friedberg JW; Little RF; Bartlett NL; Wilson WH
Lancet Haematol; 2018 Dec; 5(12):e609-e617. PubMed ID: 30501868
[TBL] [Abstract][Full Text] [Related]
51. The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma.
Sohn BS; Kim SM; Yoon DH; Kim S; Lee DH; Kim JH; Lee SW; Huh J; Suh C
Ann Hematol; 2012 Nov; 91(11):1731-9. PubMed ID: 22752193
[TBL] [Abstract][Full Text] [Related]
52. Treatment of prognosis of primary breast lymphoma: a review of 13 cases.
Lyons JA; Myles J; Pohlman B; Macklis RM; Crowe J; Crownover RL
Am J Clin Oncol; 2000 Aug; 23(4):334-6. PubMed ID: 10955857
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C
Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777
[TBL] [Abstract][Full Text] [Related]
54. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy.
Lee S; Kim DH; Oh SY; Kim SY; Koh MS; Lee JH; Lee S; Kim SH; Kwak JY; Pak MG; Ju MH; Kim HJ; Jeong JS
Korean J Intern Med; 2017 Mar; 32(2):335-344. PubMed ID: 26968188
[TBL] [Abstract][Full Text] [Related]
56. Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey.
Mertsoylu H; Muallaoglu S; Besen AA; Erdogdu S; Sezer A; Sedef AM; Kose F; Arican A; Ozyilkan O
Asian Pac J Cancer Prev; 2014; 15(17):7207-11. PubMed ID: 25227815
[TBL] [Abstract][Full Text] [Related]
57. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M; Ross CW; Hsi ED
Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
[TBL] [Abstract][Full Text] [Related]
58. Outcome analysis for stage IE and IIE thyroid lymphoma.
DiBiase SJ; Grigsby PW; Guo C; Lin HS; Wasserman TH
Am J Clin Oncol; 2004 Apr; 27(2):178-84. PubMed ID: 15057158
[TBL] [Abstract][Full Text] [Related]
59. Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
Lee JY; Kang M; Suh KJ; Kim JW; Kim SH; Kim JW; Kim YJ; Song KH; Kim ES; Kim HB; Lee KW; Kim JH; Bang SM; Lee JS; Lee JO
Mycoses; 2021 Jan; 64(1):60-65. PubMed ID: 32970331
[TBL] [Abstract][Full Text] [Related]
60. Diffuse large B-cell lymphoma: A retrospective study from a regional care center in South India.
Babu SM; Garg S; Kanakasetty GB; Kuntegowdanahalli LC; Dasappa L; Rao SA
Indian J Cancer; 2018; 55(1):66-69. PubMed ID: 30147096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
